The results showed that several tumor-related pathways were enriched in the high-risk group, such as the AML (Fig. 8a), vascular endothelial growth factor (VEGF, Fig. 8b), and mitogen-activated protein kinase (MAPK, Fig. 8c) signaling pathways. Here, WNK2 is linked to acute myeloid leukemia.